Sort
51,570 grants matching “autoimmune disease”
Antibody Mediated Immune Regulation
$534,598James C. Zimring · University Of Virginia · P01 · FY2020 · HL
Role of the Factor H Related Proteins in Kidney Disease
$534,582Joshua M Thurman · University Of Colorado Denver · R01 · FY2024 · DK
Role for nuclear matrix proteins and DNA methylation for XCI maintenance in female lymphocytes
$534,526Montserrat C Anguera · University Of Pennsylvania · R01 · FY2025 · AI
Specificity and Molecular Definition of Pathogenic Lymphocytes in Sjogren's Syndrome
$534,514A. Darise Farris · Oklahoma Medical Research Foundation · R01 · FY2019 · AR
EPIDEMIOLOGY OF PRIMARY BILIARY CIRRHOSIS
$534,493University Of California Davis · R01 · FY2000 · DK
Clinical Investigations In Infectious And Autoimmune Diseases
$534,470Sharon M Wahl · Dental & Craniofacial Research · Z01 · FY2007 · DE
JUVENILE DIABETES MELLITUS: EPIDEMIOLOGY AND ETIOLOGY
$534,467Dorothy J Becker · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · DK
THE PATHOGENESIS OF AUTOIMMUNITY IN A MURINE MODEL OF PRIMARY BILIARY CIRRHOSIS
$534,444Merrill E Gershwin · University Of California At Davis · R01 · FY2010 · DK
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
$534,418Ginny L Bumgardner · Ohio State University · R01 · FY2023 · AI
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
$534,418Ginny L Bumgardner · Ohio State University · R01 · FY2022 · AI
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
$534,418Ginny L Bumgardner · Ohio State University · R01 · FY2020 · AI
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
$534,418Ginny L Bumgardner · Ohio State University · R01 · FY2021 · AI
The Role of Inflammation in Regulating Gastric Metaplasia
$534,362Richard J Dipaolo · Saint Louis University · R01 · FY2024 · DK
Cellular Therapies for Tolerance Induction
$534,359Leslie S Kean · Emory University · U19 · FY2015 · AI
T-Cell Targeting for GVHD
$534,296Bruce R. Blazar · University Of Minnesota · R01 · FY2020 · HL
Defining and Controlling Protein-RNA interactions in editing and interference pathways
$534,280Peter A. Beal · University Of California At Davis · R35 · FY2025 · GM
Regulation of Gut Innate Lymphoid Cells by Ahr
$534,256Liang Zhou · University Of Florida · R01 · FY2017 · AI
Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases
$534,136Stephen I Katz · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Ca2+ signaling via SOCE in the pathogenesis of Sjögrenâs syndrome
$534,120Stefan Feske · New York University School Of Medicine · R01 · FY2020 · DE
Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence
$534,090Philip J Goulder · University Of Oxford · U01 · FY2023 · AI
CD24 Targeting for Multiple Sclerosis: a First-In-Human Phase I Study
$534,084Yang Liu · Oncoimmune, Inc. · R01 · FY2014 · NS
WAVE Regulatory Complex in Primary Immunodeficiency Disease and autoimmunity
$534,041Brian M Iritani · University Of Washington · R01 · FY2022 · AI
Understanding mechanisms and consequences of T cell co-receptor regulated RNA maturation
$533,970Scott Henry Olejniczak · Roswell Park Cancer Institute Corp · R01 · FY2021 · AI
Rescue of Autoimmune-Associated Long QT Syndrome by Decoy Peptides
$533,948Mohamed Boutjdir · Narrows Institute For Biomedical Res Inc · R01 · FY2024 · HL
T-Cell Targeting for GVHD
$533,936Bruce R. Blazar · University Of Minnesota · R01 · FY2021 · HL